Prostaglandin F2α-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 12, 2009, Pages 1917-1928

  Sales, Kurt J ^a   Maldonado Pérez, David ^a   Grant, Vivien ^a   Catalano, Rob D ^a   Wilson, Martin R ^a   Brown, Pamela ^a   Williams, Alistair R W ^a   Anderson, Richard A ^a   Thompson, E Aubrey ^b   Jabbour, Henry N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

Calcineurin; Chemokine; CXCL8; FP receptor; PGF2 ; Prostaglandin

Indexed keywords

CALCINEURIN; CALCIUM; F PROSTANOID RECEPTOR; INTERLEUKIN 8; PROSTAGLANDIN F2 ALPHA; PROSTANOID RECEPTOR; PROTEIN KINASE C; REGULATOR OF CALCINEURIN 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; IL8 PROTEIN, HUMAN; PROSTAGLANDIN F2ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; DNA RESPONSIVE ELEMENT; ENDOMETRIUM TUMOR; METABOLISM; NUDE MOUSE; TUMOR CELL LINE; XENOGRAFT;

ADENOVIRIDAE; MUS MUSCULUS;

ADENOCARCINOMA; ANIMALS; CALCINEURIN; CALCIUM; CELL LINE, TUMOR; DINOPROST; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NFATC TRANSCRIPTION FACTORS; PROTEIN KINASE C; RECEPTORS, PROSTAGLANDIN; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 72049130544     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.09.018     Document Type: Article

References (53)

1. Baird D.T., Cameron S.T., Critchley H.O., Drudy T.A., Howe A., Jones R.L., Lea R.G., and Kelly R.W. Prostaglandins and menstruation. Eur. J. Obstet. Gynecol. Reprod. Biol. 70 (1996) 15-17
2. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
3. Robinson W. Hepatitis B virus and hepatocellular carcinoma. In: Parsonnet J. (Ed). Microbes and malignancy: infection as a cause of human cancers (1999), Oxford University Press, New York 232-266
4. Lewis J.D., Deren J.J., and Lichtenstein G.R. Cancer risk in patients with inflammatory bowel disease. Gastroenterol. Clin. North Am. 28 (1999) 459-477
5. Mant J.W., and Vessey M.P. Ovarian and endometrial cancers. Cancer Surv. 20 (1994) 287-307
6. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J. Steroid Biochem. Mol. Biol. 74 (2000) 357-364
7. Parazzini F., La Vecchia C., Bocciolone L., and Franceschi S. The epidemiology of endometrial cancer. Gynecol. Oncol. 41 (1991) 1-16
8. Jabbour H.N., Milne S.A., Williams A.R.W., Anderson R.A., and Boddy S.C. Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br. J. Cancer 85 (2001) 1023-1031
9. Sales K.J., Boddy S.C., Williams A.R., Anderson R.A., and Jabbour H.N. F-prostanoid receptor regulation of fibroblast growth factor 2 signalling in endometrial adenocarcinoma cells. Endocrinology 148 (2007) 3635-3644
10. Sales K.J., List T., Boddy S.C., Williams A.R., Anderson R.A., Naor Z., and Jabbour H.N. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res. 65 (2005) 7707-7716
11. Tong B.J., Tan J., Tajeda L., Das S.K., Chapman J.A., DuBois R.N., and Dey S.K. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-{delta} in human endometrial adenocarcinoma. Neoplasia 2 (2000) 483-490
12. Jabbour H.N., and Sales K.J. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol. Metab. 15 (2004) 398-404
13. Sales K.J., and Jabbour H.N. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 126 (2003) 559-567
14. Kayisli U.A., Mahutte N.G., and Arici A. Uterine chemokines in reproductive physiology and pathology. Am. J. Reprod. Immunol. 47 (2002) 213-221
15. Wang D., Wang H., Brown J., Daikoku T., Ning W., Shi Q., Richmond A., Strieter R., Dey S.K., and DuBois R.N. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 203 (2006) 941-951
16. Wallace A.E., Sales K.J., Catalano R.D., Anderson R.A., Williams A.R., Wilson M.R., Schwarze J., Wang H., Rossi A.G., and Jabbour H.N. Prostaglandin F2{alpha}-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma. Cancer Res. 69 (2009) 5726-5733
17. Richmond A., and Thomas H.G. Purification of melanoma growth stimulatory activity. J. Cell. Physiol. 129 (1986) 375-384
18. Wislez M., Fujimoto N., Izzo J.G., Hanna A.E., Cody D.D., Langley R.R., Tang H., Burdick M.D., Sato M., Minna J.D., Mao L., Wistuba I., Strieter R.M., and Kurie J.M. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res. 66 (2006) 4198-4207
19. Bieche I., Chavey C., Andrieu C., Busson M., Vacher S., Le Corre L., Guinebretiere J.M., Burlinchon S., Lidereau R., and Lazennec G. CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr. Relat. Cancer 14 (2007) 1039-1052
20. Ludes-Meyers J.H., Liu Y., Munoz-Medellin D., Hilsenbeck S.G., and Brown P.H. AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene 20 (2001) 2771-2780
21. Yamaoka Y., Kudo T., Lu H., Casola A., Brasier A.R., and Graham D.Y. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology 126 (2004) 1030-1043
22. Casola A., Garofalo R.P., Jamaluddin M., Vlahopoulos S., and Brasier A.R. Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J. Immunol. 164 (2000) 5944-5951
23. Sales K.J., Grant V., and Jabbour H.N. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol. Cell. Endocrinol. 285 (2008) 51-61
24. Sales K.J., Milne S.A., Williams A.R., Anderson R.A., and Jabbour H.N. Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways. J. Clin. Endocrinol. Metab. 89 (2004) 986-993
25. Maldonado-Perez D., Brown P., Morgan K., Millar R.P., Thompson E.A., and Jabbour H.N. Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway. Biochim. Biophys. Acta 1793 (2009) 1315-1324
26. Denison F.C., Riley S.C., Wathen N.C., Chard T., Calder A.A., and Kelly R.W. Differential concentrations of monocyte chemotactic protein-1 and interleukin-8 within the fluid compartments present during the first trimester of pregnancy. Hum. Reprod. 13 (1998) 2292-2295
27. Minami T., Horiuchi K., Miura M., Abid M.R., Takabe W., Noguchi N., Kohro T., Ge X., Aburatani H., Hamakubo T., Kodama T., and Aird W.C. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J. Biol. Chem. 279 (2004) 50537-50554
28. Erlanson D.A., Chytil M., and Verdine G.L. The leucine zipper domain controls the orientation of AP-1 in the NFAT.AP-1.DNA complex. Chem. Biol. 3 (1996) 981-991
29. Ramirez-Carrozzi V.R., and Kerppola T.K. Control of the orientation of Fos-Jun binding and the transcriptional cooperativity of Fos-Jun-NFAT1 complexes. J. Biol. Chem. 276 (2001) 21797-21808
30. Ramirez-Carrozzi V.R., and Kerppola T.K. Dynamics of Fos-Jun-NFAT1 complexes. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4893-4898
31. Macian F., Lopez-Rodriguez C., and Rao A. Partners in transcription: NFAT and AP-1. Oncogene 20 (2001) 2476-2489
32. Davies K.J., Ermak G., Rothermel B.A., Pritchard M., Heitman J., Ahnn J., Henrique-Silva F., Crawford D., Canaider S., Strippoli P., Carinci P., Min K.T., Fox D.S., Cunningham K.W., Bassel-Duby R., Olson E.N., Zhang Z., Williams R.S., Gerber H.P., Perez-Riba M., Seo H., Cao X., Klee C.B., Redondo J.M., Maltais L.J., Bruford E.A., Povey S., Molkentin J.D., McKeon F.D., Duh E.J., Crabtree G.R., Cyert M.S., de la Luna S., and Estivill X. Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J. 21 (2007) 3023-3028
33. Chan B., Greenan G., McKeon F., and Ellenberger T. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13075-13080
34. Christofakis E.P., Miyazaki H., Rubink D.S., and Yeudall W.A. Roles of CXCL8 in squamous cell carcinoma proliferation and migration. Oral Oncol. (2008) 920-926
35. Perwez Hussain S., and Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 121 (2007) 2373-2380
36. Arici A., Seli E., Senturk L.M., Gutierrez L.S., Oral E., and Taylor H.S. Interleukin-8 in the human endometrium. J. Clin. Endocrinol. Metab. 83 (1998) 1783-1787
37. Arici A., Seli E., Zeyneloglu H.B., Senturk L.M., Oral E., and Olive D.L. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J. Clin. Endocrinol. Metab. 83 (1998) 1201-1205
38. Ulukus M., Ulukus E.C., Seval Y., Zheng W., and Arici A. Expression of interleukin-8 receptors in endometriosis. Hum. Reprod. 20 (2005) 794-801
39. Sun L.J., Peterson B.R., and Verdine G.L. Dual role of the nuclear factor of activated T cells insert region in DNA recognition and cooperative contacts to activator protein 1. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4919-4924
40. Huang S., Mills L., Mian B., Tellez C., McCarty M., Yang X.D., Gudas J.M., and Bar-Eli M. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am. J. Pathol. 161 (2002) 125-134
41. Krzystek-Korpacka M., Matusiewicz M., Diakowska D., Grabowski K., Blachut K., Konieczny D., Kustrzeba-Wojcicka I., Terlecki G., and Banas T. Elevation of circulating interleukin-8 is related to lymph node and distant metastases in esophageal squamous cell carcinomas-implication for clinical evaluation of cancer patient. Cytokine 41 (2008) 232-239
42. Griffin B.W., Klimko P., Crider J.Y., and Sharif N.A. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J. Pharmacol. Exp. Ther. 290 (1999) 1278-1284
43. Takasaki J., Saito T., Taniguchi M., Kawasaki T., Moritani Y., Hayashi K., Kobori M., and novel A. Galphaq/11-selective inhibitor. J. Biol. Chem 279 (2004) 47438-47445
44. Taniguchi M., Suzumura K., Nagai K., Kawasaki T., Takasaki J., Sekiguchi M., Moritani Y., Saito T., Hayashi K., Fujita S., Tsukamoto S., and Suzuki K. YM-254890 analogues, novel cyclic depsipeptides with Galpha(q/11) inhibitory activity from Chromobacterium sp. QS3666. Bioorg. Med. Chem. 12 (2004) 3125-3133
45. Bleasdale J.E., Thakur N.R., Gremban R.S., Bundy G.L., Fitzpatrick F.A., Smith R.J., and Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther. 255 (1990) 756-768
46. Lu Z.X., Quazi N.H., Deady L.W., and Polya G.M. Selective inhibition of cyclic AMP-dependent protein kinase by isoquinoline derivatives. Biol. Chem. 377 (1996) 373-384
47. Beltman J., McCormick F., and Cook S.J. The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J. Biol. Chem. 271 (1996) 27018-27024
48. Roehrl M.H., Kang S., Aramburu J., Wagner G., Rao A., and Hogan P.G. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7554-7559
49. De Boer M.L., Mordvinov V.A., Thomas M.A., and Sanderson C.J. Role of nuclear factor of activated T cells (NFAT) in the expression of interleukin-5 and other cytokines involved in the regulation of hemopoetic cells. Int. J. Biochem. Cell Biol. 31 (1999) 1221-1236
50. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., and Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270 (1995) 14255-14258
51. Zhou X.F., Shen X.Q., and Shemshedini L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol. Endocrinol. 13 (1999) 276-285
52. Qin N., Olcese R., Bransby M., Lin T., and Birnbaumer L. Ca2+-induced inhibition of the cardiac Ca2+ channel depends on calmodulin. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2435-2438
53. White J.R., Lee J.M., Young P.R., Hertzberg R.P., Jurewicz A.J., Chaikin M.A., Widdowson K., Foley J.J., Martin L.D., Griswold D.E., and Sarau H.M. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J. Biol. Chem. 273 (1998) 10095-10098